← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Angiodrox currently has availability issues reported in 1 European register: Spain.
Shortage ATC — · also listed as: ANGIODROX · data refreshed 10 September 2026
As of 10 September 2026, 1 of the 9 tracked registers list current availability issues for Angiodrox, covering 2 affected product presentations. The longest-running open report was filed in Spain on 2026-07-01 and has now been open for about 2 months. The furthest expected-resolution date currently on file is 2026-10-08; the earliest is 2026-09-29. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. Registers in Spain indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇪🇸 Spain | Shortage ANGIODROX 180 mg CAPSULAS DURAS DE LIBERACION PROLONGADA , 30 cápsulas + 1 more productsANGIODROX 300 mg CAPSULAS DURAS DE LIBERACION PROLONGADA , 30 cápsulas | 2026-07-01 | 2026-10-08 | Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. | register ↗ |
Every individual register entry for Angiodrox in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇪🇸 ES | ANGIODROX 300 mg CAPSULAS DURAS DE LIBERACION PROLONGADA , 30 cápsulas | Shortage | 2026-08-17 | 2026-09-29 | Existen otros medicamentos con el mismo principio activo y m |
| 🇪🇸 ES | ANGIODROX 180 mg CAPSULAS DURAS DE LIBERACION PROLONGADA , 30 cápsulas | Shortage | 2026-07-01 | 2026-10-08 | Existen otros medicamentos con el mismo principio activo y m |
Yes. As of 10 September 2026, availability issues are reported in: Spain. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-29 to 2026-10-08. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency register that lists Angiodrox: AEMPS CIMA (Spain). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Angiodrox — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/angiodrox/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Angiodrox availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/angiodrox/">Angiodrox shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>